If you\’re researching peptides for muscle growth, fat loss, or anti-aging, you\’ve almost certainly come across CJC-1295 and Ipamorelin. This combination is by far the most popular growth hormone-stimulating stack in the research community — and for good reason. Let\’s break it down in plain terms.
What Are CJC-1295 and Ipamorelin?
CJC-1295 and Ipamorelin are two separate peptides that work together to stimulate your body to produce more of its own growth hormone (GH). They are not growth hormone itself — they tell your pituitary gland to release more GH naturally.
CJC-1295 is a GHRH (growth hormone releasing hormone) analog. It acts on receptors in the pituitary gland to stimulate GH release. The version most commonly used is CJC-1295 with DAC (Drug Affinity Complex), which extends its half-life to around 8 days — meaning injections are only needed once or twice per week.
Ipamorelin is a GHRP (growth hormone releasing peptide). It stimulates GH release through a different receptor (the ghrelin receptor) and is known for producing a clean, stable pulse of GH with minimal side effects compared to other GHRPs.
Why Are They Used Together?
CJC-1295 and Ipamorelin work on two different pathways that both lead to GH release. When used together, they produce a synergistic effect — the combined GH pulse is significantly stronger than either peptide alone.
- → CJC-1295 = pushes the accelerator on your body\’s GH-releasing system
- → Ipamorelin = pushes a separate, complementary accelerator
- → Together = significantly more GH output than either alone
What Are the Benefits?
Higher growth hormone levels produce a range of downstream effects:
- → Increased lean muscle mass
- → Reduced body fat, especially visceral fat
- → Improved recovery from training and injury
- → Better sleep quality (GH is primarily released during deep sleep)
- → Improved skin quality, collagen production, and overall anti-aging effects
- → Higher energy levels and sense of well-being
- → Improved bone density
How Is This Stack Typically Used?
Common research protocols for CJC-1295 + Ipamorelin:
- → Ipamorelin dose: 100–300 mcg per injection
- → CJC-1295 (with DAC) dose: 1–2 mg per injection, 1–2x per week
- → Timing: Ipamorelin is often taken before bed to align with natural GH pulses during sleep
- → Cycle length: 12–24 weeks is common in research protocols
⚠️ Important: These are for research purposes only. Not approved for human use. Always consult a healthcare professional.
Side Effects
The CJC-1295 + Ipamorelin stack is generally considered to have a mild side effect profile:
- → Water retention (especially early on)
- → Tingling or numbness in hands and feet
- → Mild fatigue or tiredness after injection
- → Headaches
- → Increased appetite (less common with Ipamorelin than other GHRPs)
Quick Reference
| Factor | Details |
|---|---|
| Peptide Types | GHRH analog (CJC-1295) + GHRP (Ipamorelin) |
| Mechanism | Stimulates pituitary to release natural growth hormone |
| Main Benefits | Muscle growth, fat loss, recovery, anti-aging, sleep |
| CJC-1295 Dose | 1–2 mg, 1–2x per week (DAC version) |
| Ipamorelin Dose | 100–300 mcg per injection |
| Status | Research use only — not FDA approved |
The Bottom Line
CJC-1295 + Ipamorelin is the most researched and most commonly used GH-stimulating peptide stack available. It\’s popular because it works through your body\’s own natural GH system, has a favorable side effect profile, and delivers results consistent with elevated GH levels. If you\’re researching growth hormone peptides, this stack is the standard starting point.
// Where to Source
All suppliers listed below have been vetted by TalkPeps for COA transparency and product quality. Use the exclusive discount codes to save on your order.
TalkPeps may earn a commission on purchases at no extra cost to you. Research compounds only — not for human therapeutic use.